131 related articles for article (PubMed ID: 35395370)
21. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors.
Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH
Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4-amino-5-cyanopyrimidine) derivatives.
Boualia I; Derabli C; Boulcina R; Bensouici C; Yildirim M; Birinci Yildirim A; Mokrani EH; Debache A
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900027. PubMed ID: 31448454
[TBL] [Abstract][Full Text] [Related]
23. Microwave-Assisted Synthesis of (Piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as Potent Inhibitors of Cholinesterases: A Biochemical and In Silico Approach.
Munir R; Zia-Ur-Rehman M; Murtaza S; Zaib S; Javid N; Awan SJ; Iftikhar K; Athar MM; Khan I
Molecules; 2021 Jan; 26(3):. PubMed ID: 33513837
[TBL] [Abstract][Full Text] [Related]
24. Scrophularia lucida L. as a valuable source of bioactive compounds for pharmaceutical applications: In vitro antioxidant, anti-inflammatory, enzyme inhibitory properties, in silico studies, and HPLC profiles.
Zengin G; Stefanucci A; Rodrigues MJ; Mollica A; Custodio L; Aumeeruddy MZ; Mahomoodally MF
J Pharm Biomed Anal; 2019 Jan; 162():225-233. PubMed ID: 30268023
[TBL] [Abstract][Full Text] [Related]
25. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI
Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel 1,2,3 triazole derivatives and assessment of their potential cholinesterases, glutathione S-transferase enzymes inhibitory properties: An in vitro and in silico study.
Çelik F; Türkan F; Aras A; Atalar MN; Karaman HS; Ünver Y; Kahriman N
Bioorg Chem; 2021 Feb; 107():104606. PubMed ID: 33476865
[TBL] [Abstract][Full Text] [Related]
28. Phytochemical profile, enzyme inhibition activity and molecular docking analysis of
Saber FR; Ashour RM; El-Halawany AM; Mahomoodally MF; Ak G; Zengin G; Mahrous EA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):618-626. PubMed ID: 33557639
[No Abstract] [Full Text] [Related]
29. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors.
Kia Y; Osman H; Suresh Kumar R; Basiri A; Murugaiyah V
Bioorg Med Chem Lett; 2014 Apr; 24(7):1815-9. PubMed ID: 24594354
[TBL] [Abstract][Full Text] [Related]
31. Tetrahydroquinoline-Isoxazole/Isoxazoline Hybrid Compounds as Potential Cholinesterases Inhibitors: Synthesis, Enzyme Inhibition Assays, and Molecular Modeling Studies.
Rodríguez Núñez YA; Gutíerrez M; Alzate-Morales J; Adasme-Carreño F; Güiza FM; Bernal CC; Bohórquez ARR
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861333
[TBL] [Abstract][Full Text] [Related]
32. Two Ganoderma species: profiling of phenolic compounds by HPLC-DAD, antioxidant, antimicrobial and inhibitory activities on key enzymes linked to diabetes mellitus, Alzheimer's disease and skin disorders.
Zengin G; Sarikurkcu C; Gunes E; Uysal A; Ceylan R; Uysal S; Gungor H; Aktumsek A
Food Funct; 2015 Aug; 6(8):2794-802. PubMed ID: 26165701
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities.
Gök N; Akıncıoğlu A; Erümit Binici E; Akıncıoğlu H; Kılınç N; Göksu S
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000496. PubMed ID: 33749025
[TBL] [Abstract][Full Text] [Related]
34. Enzyme Inhibitory, Antioxidant And Antibacterial Potentials Of Synthetic Symmetrical And Unsymmetrical Thioureas.
Naz S; Zahoor M; Umar MN; Ali B; Ullah R; Shahat AA; Mahmood HM; Sahibzada MUK
Drug Des Devel Ther; 2019; 13():3485-3495. PubMed ID: 31631973
[TBL] [Abstract][Full Text] [Related]
35. Transition metal complexes of a multidentate Schiff base ligand containing pyridine: synthesis, characterization, enzyme inhibitions, antioxidant properties, and molecular docking studies.
Bursal E; Turkan F; Buldurun K; Turan N; Aras A; Çolak N; Murahari M; Yergeri MC
Biometals; 2021 Apr; 34(2):393-406. PubMed ID: 33528765
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, biological evaluation (antioxidant, antimicrobial, enzyme inhibition, and cytotoxic) and molecular docking study of hydroxy methoxy benzoin/benzil analogous.
Yaylı N; Kılıç G; Kahriman N; Kanbolat Ş; Bozdeveci A; Alpay Karaoğlu Ş; Aliyazıcıoğlu R; Erdinç Sellitepe H; Selin Doğan İ; Aydın A; Tatar G
Bioorg Chem; 2021 Oct; 115():105183. PubMed ID: 34339978
[TBL] [Abstract][Full Text] [Related]
37. Novel propanolamine derivatives attached to 2-metoxifenol moiety: Synthesis, characterization, biological properties, and molecular docking studies.
Genc Bilgicli H; Ergon D; Taslimi P; Tüzün B; Akyazı Kuru İ; Zengin M; Gülçin İ
Bioorg Chem; 2020 Aug; 101():103969. PubMed ID: 32474181
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors.
Mughal EU; Javid A; Sadiq A; Murtaza S; Zafar MN; Khan BA; Sumrra SH; Tahir MN; Kanwal ; Khan KM
Bioorg Med Chem; 2018 Jul; 26(12):3696-3706. PubMed ID: 29886083
[TBL] [Abstract][Full Text] [Related]
39. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study.
Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J
Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558
[TBL] [Abstract][Full Text] [Related]
40. Structure-based designing and synthesis of 2-phenylchromone derivatives as potent tyrosinase inhibitors: In vitro and in silico studies.
Ashraf J; Mughal EU; Alsantali RI; Obaid RJ; Sadiq A; Naeem N; Ali A; Massadaq A; Javed Q; Javid A; Sumrra SH; Zafar MN; Ahmed SA
Bioorg Med Chem; 2021 Apr; 35():116057. PubMed ID: 33610011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
